The role of breast cancer stem cells in metastasis and therapeutic implications

American Journal of Pathology

Volumn 179, Issue 1, 2011, Pages 2-11

  Velasco Velázquez, Marco A ^a,b   Popov, Vladimir M ^b   Lisanti, Michael P ^c   Pestell, Richard G ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; CAVEOLIN 1; CD24 ANTIGEN; CELL PROTEIN; DACH1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HERMES ANTIGEN; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; NEU DIFFERENTIATION FACTOR; SALINOMYCIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; BREAST CANCER; CANCER INVASION; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENICITY; CELL FATE; CELL INVASION; CELL LINEAGE; CELL MIGRATION; CELL MOTILITY; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELL SELECTION; CELL SURVIVAL; CHEMOTAXIS; CYTOKINE RELEASE; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FUNCTIONAL GENOMICS; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE POOL; GENETIC ASSOCIATION; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; MACROMETASTASIS; MESENCHYMAL STEM CELL; METASTASIS; MICROMETASTASIS; NONHUMAN; OSTEOSARCOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; TRANSGENE; TUMOR MICROENVIRONMENT;

BREAST NEOPLASMS; FEMALE; HUMANS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS;

EID: 80052479916     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.03.005     Document Type: Review

References (212)

1. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells [Erratum appeared in Proc Natl Acad Sci USA 2003, 100:6890] Proc Natl Acad Sci USA 100 2003 3983 3988
2. D. Ponti, A. Costa, N. Zaffaroni, G. Pratesi, G. Petrangolini, D. Coradini, S. Pilotti, M.A. Pierotti, and M.G. Daidone Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties Cancer Res 65 2005 5506 5511
3. C.M. Fillmore, and C. Kuperwasser Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy Breast Cancer Res 10 2008 R25
4. M.H. Wright, A.M. Calcagno, C.D. Salcido, M.D. Carlson, S.V. Ambudkar, and L. Varticovski Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics Breast Cancer Res 10 2008 R10
5. G. Dontu, W.M. Abdallah, J.M. Foley, K.W. Jackson, M.F. Clarke, M.J. Kawamura, and M.S. Wicha In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells Genes Dev 17 2003 1253 1270
6. G. Dontu, K.W. Jackson, E. McNicholas, M.J. Kawamura, W.M. Abdallah, and M.S. Wicha Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells Breast Cancer Res 6 2004 R605 R615
7. S. Corti, F. Locatelli, D. Papadimitriou, C. Donadoni, S. Salani, R. Del Bo, S. Strazzer, N. Bresolin, and G.P. Comi Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity Stem Cells 24 2006 975 985
8. D.A. Hess, T.E. Meyerrose, L. Wirthlin, T.P. Craft, P.E. Herrbrich, M.H. Creer, and J.A. Nolta Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity Blood 104 2004 1648 1655
9. C. Ginestier, M.H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, M. Brown, J. Jacquemier, P. Viens, C.G. Kleer, S. Liu, A. Schott, D. Hayes, D. Birnbaum, M.S. Wicha, and G. Dontu ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 2007 555 567
10. E. Charafe-Jauffret, C. Ginestier, F. Iovino, J. Wicinski, N. Cervera, P. Finetti, M.H. Hur, M.E. Diebel, F. Monville, J. Dutcher, M. Brown, P. Viens, L. Xerri, F. Bertucci, G. Stassi, G. Dontu, D. Birnbaum, and M.S. Wicha Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature Cancer Res 69 2009 1302 1313
11. E. Charafe-Jauffret, C. Ginestier, F. Iovino, C. Tarpin, M. Diebel, B. Esterni, G. Houvenaeghel, J.M. Extra, F. Bertucci, J. Jacquemier, L. Xerri, G. Dontu, G. Stassi, Y. Xiao, S.H. Barsky, D. Birnbaum, P. Viens, and M.S. Wicha Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer Clin Cancer Res 16 2010 45 55
12. J.C. Liu, T. Deng, R.S. Lehal, J. Kim, and E. Zacksenhaus Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors Cancer Res 67 2007 8671 8681
13. R.W. Cho, X. Wang, M. Diehn, K. Shedden, G.Y. Chen, G. Sherlock, A. Gurney, J. Lewicki, and M.F. Clarke Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors Stem Cells 26 2008 364 371
14. A. Vassilopoulos, R.H. Wang, C. Petrovas, D. Ambrozak, R. Koup, and C.X. Deng Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells Int J Biol Sci 4 2008 133 142
15. R.J. Kim, S.R. Kim, K.J. Roh, S.B. Park, J.R. Park, K.S. Kang, G. Kong, B. Tang, Y.A. Yang, E.A. Kohn, L.M. Wakefield, and J.S. Nam Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer Cancer Lett 287 2010 172 181
16. C. Sheridan, H. Kishimoto, R.K. Fuchs, S. Mehrotra, P. Bhat-Nakshatri, C.H. Turner, R. Goulet Jr, S. Badve, and H. Nakshatri CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis Breast Cancer Res 8 2006 R59
17. L. Prestegarden, and PØ Enger Cancer stem cells in the central nervous systema critical review Cancer Res 70 2010 8255 8258
18. M. Kakarala, and M.S. Wicha Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy J Clin Oncol 26 2008 2813 2820
19. S. Liu, and M.S. Wicha Targeting breast cancer stem cells J Clin Oncol 28 2010 4006 4012
20. M.S. Wicha Cancer stem cells and metastasis: lethal seeds Clin Cancer Res 12 2006 5606 5607
21. F. Li, B. Tiede, J. Massagué, and Y. Kang Beyond tumorigenesis: cancer stem cells in metastasis Cell Res 17 2007 3 14
22. A.L. Allan, S.A. Vantyghem, A.B. Tuck, and A.F. Chambers Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis Breast Dis 26 2006 87 98
23. L. Weiss Metastatic inefficiency Adv Cancer Res 54 1990 159 211
24. A.J. Minn, Y. Kang, I. Serganova, G.P. Gupta, D.D. Giri, M. Doubrovin, V. Ponomarev, W.L. Gerald, R. Blasberg, and J. Massagué Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors J Clin Invest 115 2005 44 55
25. B.K. Abraham, P. Fritz, M. McClellan, P. Hauptvogel, M. Athelogou, and H. Brauch Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis Clin Cancer Res 11 2005 1154 1159
26. B. Aktas, M. Tewes, T. Fehm, S. Hauch, R. Kimmig, and S. Kasimir-Bauer Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients Breast Cancer Res 11 2009 R46
27. P.A. Theodoropoulos, H. Polioudaki, S. Agelaki, G. Kallergi, Z. Saridaki, D. Mavroudis, and V. Georgoulias Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer Cancer Lett 288 2010 99 106
28. M. Balic, H. Lin, L. Young, D. Hawes, A. Giuliano, G. McNamara, R.H. Datar, and R.J. Cote Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype Clin Cancer Res 12 2006 5615 5621
29. F. Yu, H. Yao, P. Zhu, X. Zhang, Q. Pan, C. Gong, Y. Huang, X. Hu, F. Su, J. Lieberman, and E. Song let-7 regulates self renewal and tumorigenicity of breast cancer cells Cell 131 2007 1109 1123
30. M. Dean ABC transporters, drug resistance, and cancer stem cells J Mammary Gland Biol Neoplasia 14 2009 3 9
31. L. Lacerda, L. Pusztai, and W.A. Woodward The role of tumor initiating cells in drug resistance of breast cancer: implications for future therapeutic approaches Drug Resist Updat 13 2010 99 108
32. R. Liu, X. Wang, G.Y. Chen, P. Dalerba, A. Gurney, T. Hoey, G. Sherlock, J. Lewicki, K. Shedden, and M.F. Clarke The prognostic role of a gene signature from tumorigenic breast-cancer cells N Engl J Med 356 2007 217 226
33. V. Neumeister, S. Agarwal, J. Bordeaux, R.L. Camp, and D.L. Rimm In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis Am J Pathol 176 2010 2131 2138
34. E. Resetkova, J.S. Reis-Filho, R.K. Jain, R. Mehta, M.A. Thorat, H. Nakshatri, and S. Badve Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment Breast Cancer Res Treat 123 2010 97 108
35. P. Marcato, C.A. Dean, D. Pan, R. Araslanova, M. Gillis, M. Joshi, L. Helyer, L. Pan, A. Leidal, S. Gujar, C.A. Giacomantonio, and P.W. Lee Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis Stem Cells 29 2011 32 45
36. Y. Kang, P.M. Siegel, W. Shu, M. Drobnjak, S.M. Kakonen, C. Cordón-Cardo, T.A. Guise, and J. Massagué A multigenic program mediating breast cancer metastasis to bone Cancer Cell 3 2003 537 549
37. H. Liu, M.R. Patel, J.A. Prescher, A. Patsialou, D. Qian, J. Lin, S. Wen, Y.F. Chang, M.H. Bachmann, Y. Shimono, P. Dalerba, M. Adorno, N. Lobo, J. Bueno, F.M. Dirbas, S. Goswami, G. Somlo, J. Condeelis, C.H. Contag, S.S. Gambhir, and M.F. Clarke Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models Proc Natl Acad Sci USA 107 2010 18115 18120
38. A.K. Croker, D. Goodale, J. Chu, C. Postenka, B.D. Hedley, D.A. Hess, and A.L. Allan High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability J Cell Mol Med 13 2009 2236 2252
39. M. Shipitsin, L.L. Campbell, P. Argani, S. Weremowicz, N. Bloushtain-Qimron, J. Yao, T. Nikolskaya, T. Serebryiskaya, R. Beroukhim, M. Hu, M.K. Halushka, S. Sukumar, L.M. Parker, K.S. Anderson, L.N. Harris, J.E. Garber, A.L. Richardson, S.J. Schnitt, Y. Nikolsky, R.S. Gelman, and K. Polyak Molecular definition of breast tumor heterogeneity Cancer Cell 11 2007 259 273
40. G. Bonuccelli, M.C. Casimiro, F. Sotgia, C. Wang, M. Liu, S. Katiyar, J. Zhou, E. Dew, F. Capozza, K.M. Daumer, C. Minetti, J.N. Milliman, F. Alpy, M.C. Rio, C. Tomasetto, I. Mercier, N. Flomenberg, P.G. Frank, R.G. Pestell, and M.P. Lisanti Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature Am J Pathol 174 2009 1650 1662
41. L. Li, and W.B. Neaves Normal stem cells and cancer stem cells: the niche matters [Erratum appeared in Cancer Res 2006;66:6458] Cancer Res 66 2006 4553 4557
42. M.S. Wicha, S. Liu, and G. Dontu Cancer stem cells: an old ideaa paradigm shift Cancer Res 66 2006 1883 1890 discussion 18951886
43. T. Borovski, F. De Sousa E Melo, L. Vermeulen, and J.P. Medema Cancer stem cell niche: the place to be Cancer Res 71 2011 634 639
44. L.Y. Bourguignon, K. Peyrollier, W. Xia, and E. Gilad Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells J Biol Chem 283 2008 17635 17651
45. P. Auvinen, R. Tammi, M. Tammi, R. Johansson, and V.M. Kosma Expression of CD 44 s, CD 44 v 3 and CD 44 v 6 in benign and malignant breast lesions: correlation and colocalization with hyaluronan Histopathology 47 2005 420 428
46. D.J. Slamon, G.M. Clark, S.G. Wong, W.J. Levin, A. Ullrich, and W.L. McGuire Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 1987 177 182
47. A. Cicalese, G. Bonizzi, C.E. Pasi, M. Faretta, S. Ronzoni, B. Giulini, C. Brisken, S. Minucci, P.P. Di Fiore, and P.G. Pelicci The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells Cell 138 2009 1083 1095
48. H. Korkaya, A. Paulson, F. Iovino, and M.S. Wicha HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion Oncogene 27 2008 6120 6130
49. M. Liu, T. Sakamaki, M.C. Casimiro, N.E. Willmarth, A.A. Quong, X. Ju, J. Ojeifo, X. Jiao, W.S. Yeow, S. Katiyar, L.A. Shirley, D. Joyce, M.P. Lisanti, C. Albanese, and R.G. Pestell The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion Cancer Res 70 2010 10464 10473
50. L.Y. Bourguignon, H. Zhu, A. Chu, N. Iida, L. Zhang, and M.C. Hung Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation J Biol Chem 272 1997 27913 27918
51. L.Y. Bourguignon, E. Gilad, and K. Peyrollier Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration J Biol Chem 282 2007 19426 19441
52. L.Y. Bourguignon Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression Semin Cancer Biol 18 2008 251 259
53. M. Cariati, A. Naderi, J.P. Brown, M.J. Smalley, S.E. Pinder, C. Caldas, and A.D. Purushotham Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line Int J Cancer 122 2008 298 304
54. J. Wels, R.N. Kaplan, S. Rafii, and D. Lyden Migratory neighbors and distant invaders: tumor-associated niche cells Genes Dev 22 2008 559 574
55. M.Z. Dewan, S. Ahmed, Y. Iwasaki, K. Ohba, M. Toi, and N. Yamamoto Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer Biomed Pharmacother 60 2006 273 276
56. A. Muller, B. Homey, H. Soto, N. Ge, D. Catron, M.E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S.N. Wagner, J.L. Barrera, A. Mohar, E. Verástegui, and A. Zlotnik Involvement of chemokine receptors in breast cancer metastasis Nature 410 2001 50 56
57. M.C. Smith, K.E. Luker, J.R. Garbow, J.L. Prior, E. Jackson, D. Piwnica-Worms, and G.D. Luker CXCR4 regulates growth of both primary and metastatic breast cancer Cancer Res 64 2004 8604 8612
58. F. Andre, N. Cabioglu, H. Assi, J.C. Sabourin, S. Delaloge, A. Sahin, K. Broglio, J.P. Spano, C. Combadiere, C. Bucana, J.C. Soria, and M. Cristofanilli Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer Ann Oncol 17 2006 945 951
59. B. Psaila, R.N. Kaplan, E.R. Port, and D. Lyden Priming the 'soil' for breast cancer metastasis: the pre-metastatic niche Breast Dis 26 2006 65 74
60. W.T. Xu, Z.Y. Bian, Q.M. Fan, G. Li, and T.T. Tang Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis Cancer Lett 281 2009 32 41
61. K.E. Corcoran, K.A. Trzaska, H. Fernandes, M. Bryan, M. Taborga, V. Srinivas, K. Packman, P.S. Patel, and P. Rameshwar Mesenchymal stem cells in early entry of breast cancer into bone marrow PLoS One 3 2008 e2563
62. A.K. Sasser, N.J. Sullivan, A.W. Studebaker, L.F. Hendey, A.E. Axel, and B.M. Hall Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer FASEB J 21 2007 3763 3770
63. A.E. Karnoub, A.B. Dash, A.P. Vo, A. Sullivan, M.W. Brooks, G.W. Bell, A.L. Richardson, K. Polyak, R. Tubo, and R.A. Weinberg Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 449 2007 557 563
64. S. Pinilla, E. Alt, F.J. Abdul Khalek, C. Jotzu, F. Muehlberg, C. Beckmann, and Y.H. Song Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion Cancer Lett 284 2009 80 85
65. C. Albanese, J. Johnson, G. Watanabe, N. Eklund, D. Vu, A. Arnold, and R.G. Pestell Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions J Biol Chem 270 1995 23589 23597
66. J.M. Gee, A.F. Barroso, I.O. Ellis, J.F. Robertson, and R.I. Nicholson Biological and clinical associations of c-jun activation in human breast cancer Int J Cancer 89 2000 177 186
67. L.M. Smith, S.C. Wise, D.T. Hendricks, A.L. Sabichi, T. Bos, P. Reddy, P.H. Brown, and M.J. Birrer cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype Oncogene 18 1999 6063 6070
68. X. Jiao, S. Katiyar, N.E. Willmarth, M. Liu, X. Ma, N. Flomenberg, M.P. Lisanti, and R.G. Pestell c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion J Biol Chem 285 2010 8218 8226
69. S.R. Martini, G. Roman, S. Meuser, G. Mardon, and R.L. Davis The retinal determination gene, dachshund, is required for mushroom body cell differentiation Development 127 2000 2663 2672
70. V.M. Popov, J. Zhou, L.A. Shirley, J. Quong, W.S. Yeow, J.A. Wright, K. Wu, H. Rui, R.K. Vadlamudi, J. Jiang, R. Kumar, C. Wang, and R.G. Pestell The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling Cancer Res 69 2009 5752 5760
71. K. Wu, S. Katiyar, A. Witkiewicz, A. Li, P. McCue, L.N. Song, L. Tian, M. Jin, and R.G. Pestell The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth Cancer Res 69 2009 3347 3355
72. V.M. Popov, K. Wu, J. Zhou, M.J. Powell, G. Mardon, C. Wang, and R.G. Pestell The dachshund gene in development and hormone-responsive tumorigenesis Trends Endocrinol Metab 21 2010 41 49
73. J. Zhou, C. Wang, Z. Wang, W. Dampier, K. Wu, M.C. Casimiro, I. Chepelev, V.M. Popov, A. Quong, A. Tozeren, K. Zhao, M.P. Lisanti, and R.G. Pestell Attenuation of Forkhead signaling by the retinal determination factor DACH1 Proc Natl Acad Sci USA 107 2010 6864 6869
74. K. Wu, A. Li, M. Rao, M. Liu, V. Dailey, Y. Yang, D. Di Vizio, C. Wang, M.P. Lisanti, G. Sauter, R.G. Russell, A. Cvekl, and R.G. Pestell DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth Mol Cell Biol 26 2006 7116 7129
75. K. Wu, X. Jiao, Z. Li, S. Katiyar, M.C. Casimiro, W. Yang, Q. Zhang, N.E. Willmarth, I. Chepelev, M. Crosariol, Z. Wei, J. Hu, J. Zhao, and R.G. Pestell The cell fate determination factor dachshund reprograms breast cancer stem cell function J Biol Chem 286 2011 2132 2142
76. K. Wu, S. Katiyar, A. Li, M. Liu, X. Ju, V.M. Popov, X. Jiao, M.P. Lisanti, A. Casola, and R.G. Pestell Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8 Proc Natl Acad Sci USA 105 2008 6924 6929
77. M.S. Hayden, and S. Ghosh Signaling to NF-kappaB Genes Dev 18 2004 2195 2224
78. M. Karin The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation J Biol Chem 274 1999 27339 27342
79. P.C. Cogswell, D.C. Guttridge, W.K. Funkhouser, and A.S. Baldwin Jr Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3 Oncogene 19 2000 1123 1131
80. M.A. Pratt, T.E. Bishop, D. White, G. Yasvinski, M. Ménard, M.Y. Niu, and R. Clarke Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence Mol Cell Biol 23 2003 6887 6900
81. M. Liu, X. Ju, N.E. Willmarth, M.C. Casimiro, J. Ojeifo, T. Sakamaki, S. Katiyar, X. Jiao, V.M. Popov, Z. Yu, K. Wu, D. Joyce, C. Wang, and R.G. Pestell Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo Am J Pathol 174 2009 1910 1920
82. D. Sliva, D. English, D. Lyons, and F.P. Lloyd Jr Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB Biochem Biophys Res Commun 290 2002 552 557
83. A.B. Beshir, G. Ren, A.N. Magpusao, L.M. Barone, K.C. Yeung, and G. Fenteany Raf kinase inhibitor protein suppresses nuclear factor-kappaB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression Cancer Lett 299 2010 137 149
84. M.A. Velasco-Velázquez, Z. Yu, X. Jiao, and R.G. Pestell Cancer stem cells and the cell cycle: targeting the drive behind breast cancer Expert Rev Anticancer Ther 9 2009 275 279
85. S. Valastyan, and R.A. Weinberg MicroRNAs: crucial multi-tasking components in the complex circuitry of tumor metastasis Cell Cycle 8 2009 3506 3512
86. M. Shi, D. Liu, H. Duan, B. Shen, and N. Guo Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis Cancer Metastasis Rev 29 2010 785 799
87. Z. Yu, C. Wang, M. Wang, Z. Li, M.C. Casimiro, M. Liu, K. Wu, J. Whittle, X. Ju, T. Hyslop, P. McCue, and R.G. Pestell A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation J Cell Biol 182 2008 509 517
88. Z. Yu, N.E. Willmarth, J. Zhou, S. Katiyar, M. Wang, Y. Liu, P.A. McCue, A.A. Quong, M.P. Lisanti, and R.G. Pestell microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling Proc Natl Acad Sci USA 107 2010 8231 8236
89. M. Stahl, C. Ge, S. Shi, R.G. Pestell, and P. Stanley Notch1-induced transformation of RKE-1 cells requires up-regulation of cyclin D1 Cancer Res 66 2006 7562 7570
90. J. Lindsay, X. Jiao, T. Sakamaki, M.C. Casimiro, L.A. Shirley, T.H. Tran, X. Ju, M. Liu, Z. Li, C. Wang, S. Katiyar, M. Rao, K.G. Allen, R.I. Glazer, C. Ge, P. Stanley, M.P. Lisanti, H. Rui, and R.G. Pestell ErbB2 induces Notch1 activity and function in breast cancer cells Clin Transl Sci 1 2008 107 115
91. H. Ling, J.R. Sylvestre, and P. Jolicoeur Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors Oncogene 29 2010 4543 4554
92. Z. Li, C. Wang, G.C. Prendergast, and R.G. Pestell Cyclin D1 functions in cell migration Cell Cycle 5 2006 2440 2442
93. M. Korpal, E.S. Lee, G. Hu, and Y. Kang The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 J Biol Chem 283 2008 14910 14914
94. S.M. Park, A.B. Gaur, E. Lengyel, and M.E. Peter The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 [Erratum appeared in Genes Dev 2009;23:1378] Genes Dev 22 2008 894 907
95. U. Burk, J. Schubert, U. Wellner, O. Schmalhofer, E. Vincan, S. Spaderna, and T. Brabletz A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells EMBO Rep 9 2008 582 589
96. U. Wellner, J. Schubert, U.C. Burk, O. Schmalhofer, F. Zhu, A. Sonntag, B. Waldvogel, C. Vannier, D. Darling, A. zur Hausen, V.G. Brunton, J. Morton, O. Sansom, J. Schler, M.P. Stemmler, C. Herzberger, U. Hopt, T. Keck, S. Brabletz, and T. Brabletz The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs Nat Cell Biol 11 2009 1487 1495
97. P.C. Hermann, S.L. Huber, T. Herrler, A. Aicher, J.W. Ellwart, M. Guba, C.J. Bruns, and C. Heeschen Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1 2007 313 323
98. A.M. Tsimberidou, F.J. Giles, E. Estey, S. O'Brien, M.J. Keating, and H.M. Kantarjian The role of gemtuzumab ozogamicin in acute leukaemia therapy Br J Haematol 132 2006 398 409
99. T. Ozben Mechanisms and strategies to overcome multiple drug resistance in cancer FEBS Lett 580 2006 2903 2909
100. R. Riccioni, M.L. Dupuis, M. Bernabei, E. Petrucci, L. Pasquini, G. Mariani, M. Cianfriglia, and U. Testa The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor Blood Cells Mol Dis 45 2010 86 92
101. P.B. Gupta, T.T. Onder, G. Jiang, K. Tao, C. Kuperwasser, R.A. Weinberg, and E.S. Lander Identification of selective inhibitors of cancer stem cells by high-throughput screening Cell 138 2009 645 659
102. G. Feldmann, V. Fendrich, K. McGovern, D. Bedja, S. Bisht, H. Alvarez, J.B. Koorstra, N. Habbe, C. Karikari, M. Mullendore, K.L. Gabrielson, R. Sharma, W. Matsui, and A. Maitra An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer Mol Cancer Ther 7 2008 2725 2735
103. L. Ma, F. Reinhardt, E. Pan, J. Soutschek, B. Bhat, E.G. Marcusson, J. Teruya-Feldstein, G.W. Bell, and R.A. Weinberg Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model Nat Biotechnol 28 2010 341 347
104. V.M. Platt, and F.C. Szoka Jr Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor Mol Pharm 5 2008 474 486
105. L. Jin, K.J. Hope, Q. Zhai, F. Smadja-Joffe, and J.E. Dick Targeting of CD44 eradicates human acute myeloid leukemic stem cells Nat Med 12 2006 1167 1174
106. C. Ginestier, S. Liu, M.E. Diebel, H. Korkaya, M. Luo, M. Brown, J. Wicinski, O. Cabaud, E. Charafe-Jauffret, D. Birnbaum, J.L. Guan, G. Dontu, and M.S. Wicha CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts J Clin Invest 120 2010 485 497
107. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells [Erratum appeared in Proc Natl Acad Sci USA 2003, 100:6890] Proc Natl Acad Sci USA 100 2003 3983 3988
108. D. Ponti, A. Costa, N. Zaffaroni, G. Pratesi, G. Petrangolini, D. Coradini, S. Pilotti, M.A. Pierotti, and M.G. Daidone Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties Cancer Res 65 2005 5506 5511 (Pubitemid 40911148)
109. C.M. Fillmore, and C. Kuperwasser Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy Breast Cancer Res 10 2008 R25
110. M.H. Wright, A.M. Calcagno, C.D. Salcido, M.D. Carlson, S.V. Ambudkar, and L. Varticovski Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics Breast Cancer Res 10 2008 R10
111. G. Dontu, W.M. Abdallah, J.M. Foley, K.W. Jackson, M.F. Clarke, M.J. Kawamura, and M.S. Wicha In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells Genes Dev 17 2003 1253 1270 (Pubitemid 36583168)
112. G. Dontu, K.W. Jackson, E. McNicholas, M.J. Kawamura, W.M. Abdallah, and M.S. Wicha Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells Breast Cancer Res 6 2004 R605 R615
113. S. Corti, F. Locatelli, D. Papadimitriou, C. Donadoni, S. Salani, R. Del Bo, S. Strazzer, N. Bresolin, and G.P. Comi Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity Stem Cells 24 2006 975 985 (Pubitemid 44464730)
114. D.A. Hess, T.E. Meyerrose, L. Wirthlin, T.P. Craft, P.E. Herrbrich, M.H. Creer, and J.A. Nolta Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity Blood 104 2004 1648 1655 (Pubitemid 39202270)
115. C. Ginestier, M.H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, M. Brown, J. Jacquemier, P. Viens, C.G. Kleer, S. Liu, A. Schott, D. Hayes, D. Birnbaum, M.S. Wicha, and G. Dontu ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 2007 555 567 (Pubitemid 350056407)
116. E. Charafe-Jauffret, C. Ginestier, F. Iovino, J. Wicinski, N. Cervera, P. Finetti, M.H. Hur, M.E. Diebel, F. Monville, J. Dutcher, M. Brown, P. Viens, L. Xerri, F. Bertucci, G. Stassi, G. Dontu, D. Birnbaum, and M.S. Wicha Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature Cancer Res 69 2009 1302 1313
117. E. Charafe-Jauffret, C. Ginestier, F. Iovino, C. Tarpin, M. Diebel, B. Esterni, G. Houvenaeghel, J.M. Extra, F. Bertucci, J. Jacquemier, L. Xerri, G. Dontu, G. Stassi, Y. Xiao, S.H. Barsky, D. Birnbaum, P. Viens, and M.S. Wicha Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer Clin Cancer Res 16 2010 45 55
118. J.C. Liu, T. Deng, R.S. Lehal, J. Kim, and E. Zacksenhaus Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors Cancer Res 67 2007 8671 8681 (Pubitemid 47437442)
119. R.W. Cho, X. Wang, M. Diehn, K. Shedden, G.Y. Chen, G. Sherlock, A. Gurney, J. Lewicki, and M.F. Clarke Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors Stem Cells 26 2008 364 371 (Pubitemid 351413596)
120. A. Vassilopoulos, R.H. Wang, C. Petrovas, D. Ambrozak, R. Koup, and C.X. Deng Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells Int J Biol Sci 4 2008 133 142 (Pubitemid 351872048)
121. R.J. Kim, S.R. Kim, K.J. Roh, S.B. Park, J.R. Park, K.S. Kang, G. Kong, B. Tang, Y.A. Yang, E.A. Kohn, L.M. Wakefield, and J.S. Nam Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer Cancer Lett 287 2010 172 181
122. C. Sheridan, H. Kishimoto, R.K. Fuchs, S. Mehrotra, P. Bhat-Nakshatri, C.H. Turner, R. Goulet Jr, S. Badve, and H. Nakshatri CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis Breast Cancer Res 8 2006 R59
123. L. Prestegarden, and PØ Enger Cancer stem cells in the central nervous systema critical review Cancer Res 70 2010 8255 8258
124. M. Kakarala, and M.S. Wicha Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy J Clin Oncol 26 2008 2813 2820
125. S. Liu, and M.S. Wicha Targeting breast cancer stem cells J Clin Oncol 28 2010 4006 4012
126. M.S. Wicha Cancer stem cells and metastasis: lethal seeds Clin Cancer Res 12 2006 5606 5607 (Pubitemid 44629584)
127. F. Li, B. Tiede, J. Massagué, and Y. Kang Beyond tumorigenesis: cancer stem cells in metastasis Cell Res 17 2007 3 14 (Pubitemid 46096419)
128. A.L. Allan, S.A. Vantyghem, A.B. Tuck, and A.F. Chambers Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis Breast Dis 26 2006 87 98 (Pubitemid 46655481)
129. L. Weiss Metastatic inefficiency Adv Cancer Res 54 1990 159 211 (Pubitemid 20088338)
130. A.J. Minn, Y. Kang, I. Serganova, G.P. Gupta, D.D. Giri, M. Doubrovin, V. Ponomarev, W.L. Gerald, R. Blasberg, and J. Massagué Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors J Clin Invest 115 2005 44 55 (Pubitemid 40385504)
131. B.K. Abraham, P. Fritz, M. McClellan, P. Hauptvogel, M. Athelogou, and H. Brauch Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis Clin Cancer Res 11 2005 1154 1159 (Pubitemid 40175765)
132. B. Aktas, M. Tewes, T. Fehm, S. Hauch, R. Kimmig, and S. Kasimir-Bauer Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients Breast Cancer Res 11 2009 R46
133. P.A. Theodoropoulos, H. Polioudaki, S. Agelaki, G. Kallergi, Z. Saridaki, D. Mavroudis, and V. Georgoulias Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer Cancer Lett 288 2010 99 106
134. M. Balic, H. Lin, L. Young, D. Hawes, A. Giuliano, G. McNamara, R.H. Datar, and R.J. Cote Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype Clin Cancer Res 12 2006 5615 5621 (Pubitemid 44629587)
135. F. Yu, H. Yao, P. Zhu, X. Zhang, Q. Pan, C. Gong, Y. Huang, X. Hu, F. Su, J. Lieberman, and E. Song let-7 regulates self renewal and tumorigenicity of breast cancer cells Cell 131 2007 1109 1123 (Pubitemid 350235025)
136. M. Dean ABC transporters, drug resistance, and cancer stem cells J Mammary Gland Biol Neoplasia 14 2009 3 9
137. L. Lacerda, L. Pusztai, and W.A. Woodward The role of tumor initiating cells in drug resistance of breast cancer: implications for future therapeutic approaches Drug Resist Updat 13 2010 99 108
138. R. Liu, X. Wang, G.Y. Chen, P. Dalerba, A. Gurney, T. Hoey, G. Sherlock, J. Lewicki, K. Shedden, and M.F. Clarke The prognostic role of a gene signature from tumorigenic breast-cancer cells N Engl J Med 356 2007 217 226 (Pubitemid 46143225)
139. V. Neumeister, S. Agarwal, J. Bordeaux, R.L. Camp, and D.L. Rimm In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis Am J Pathol 176 2010 2131 2138
140. E. Resetkova, J.S. Reis-Filho, R.K. Jain, R. Mehta, M.A. Thorat, H. Nakshatri, and S. Badve Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment Breast Cancer Res Treat 123 2010 97 108
141. P. Marcato, C.A. Dean, D. Pan, R. Araslanova, M. Gillis, M. Joshi, L. Helyer, L. Pan, A. Leidal, S. Gujar, C.A. Giacomantonio, and P.W. Lee Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis Stem Cells 29 2011 32 45
142. Y. Kang, P.M. Siegel, W. Shu, M. Drobnjak, S.M. Kakonen, C. Cordón-Cardo, T.A. Guise, and J. Massagué A multigenic program mediating breast cancer metastasis to bone Cancer Cell 3 2003 537 549 (Pubitemid 36808649)
143. H. Liu, M.R. Patel, J.A. Prescher, A. Patsialou, D. Qian, J. Lin, S. Wen, Y.F. Chang, M.H. Bachmann, Y. Shimono, P. Dalerba, M. Adorno, N. Lobo, J. Bueno, F.M. Dirbas, S. Goswami, G. Somlo, J. Condeelis, C.H. Contag, S.S. Gambhir, and M.F. Clarke Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models Proc Natl Acad Sci USA 107 2010 18115 18120
144. A.K. Croker, D. Goodale, J. Chu, C. Postenka, B.D. Hedley, D.A. Hess, and A.L. Allan High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability J Cell Mol Med 13 2009 2236 2252
145. M. Shipitsin, L.L. Campbell, P. Argani, S. Weremowicz, N. Bloushtain-Qimron, J. Yao, T. Nikolskaya, T. Serebryiskaya, R. Beroukhim, M. Hu, M.K. Halushka, S. Sukumar, L.M. Parker, K.S. Anderson, L.N. Harris, J.E. Garber, A.L. Richardson, S.J. Schnitt, Y. Nikolsky, R.S. Gelman, and K. Polyak Molecular definition of breast tumor heterogeneity Cancer Cell 11 2007 259 273 (Pubitemid 46349843)
146. G. Bonuccelli, M.C. Casimiro, F. Sotgia, C. Wang, M. Liu, S. Katiyar, J. Zhou, E. Dew, F. Capozza, K.M. Daumer, C. Minetti, J.N. Milliman, F. Alpy, M.C. Rio, C. Tomasetto, I. Mercier, N. Flomenberg, P.G. Frank, R.G. Pestell, and M.P. Lisanti Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature Am J Pathol 174 2009 1650 1662
147. L. Li, and W.B. Neaves Normal stem cells and cancer stem cells: the niche matters [Erratum appeared in Cancer Res 2006;66:6458] Cancer Res 66 2006 4553 4557
148. M.S. Wicha, S. Liu, and G. Dontu Cancer stem cells: an old ideaa paradigm shift Cancer Res 66 2006 1883 1890 discussion 18951886
149. T. Borovski, F. De Sousa E Melo, L. Vermeulen, and J.P. Medema Cancer stem cell niche: the place to be Cancer Res 71 2011 634 639
150. L.Y. Bourguignon, K. Peyrollier, W. Xia, and E. Gilad Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells J Biol Chem 283 2008 17635 17651
151. P. Auvinen, R. Tammi, M. Tammi, R. Johansson, and V.M. Kosma Expression of CD 44 s, CD 44 v 3 and CD 44 v 6 in benign and malignant breast lesions: correlation and colocalization with hyaluronan Histopathology 47 2005 420 428 (Pubitemid 41428491)
152. D.J. Slamon, G.M. Clark, S.G. Wong, W.J. Levin, A. Ullrich, and W.L. McGuire Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 1987 177 182 (Pubitemid 17231334)
153. A. Cicalese, G. Bonizzi, C.E. Pasi, M. Faretta, S. Ronzoni, B. Giulini, C. Brisken, S. Minucci, P.P. Di Fiore, and P.G. Pelicci The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells Cell 138 2009 1083 1095
154. H. Korkaya, A. Paulson, F. Iovino, and M.S. Wicha HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion Oncogene 27 2008 6120 6130
155. M. Liu, T. Sakamaki, M.C. Casimiro, N.E. Willmarth, A.A. Quong, X. Ju, J. Ojeifo, X. Jiao, W.S. Yeow, S. Katiyar, L.A. Shirley, D. Joyce, M.P. Lisanti, C. Albanese, and R.G. Pestell The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion Cancer Res 70 2010 10464 10473
156. L.Y. Bourguignon, H. Zhu, A. Chu, N. Iida, L. Zhang, and M.C. Hung Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation J Biol Chem 272 1997 27913 27918 (Pubitemid 27473595)
157. L.Y. Bourguignon, E. Gilad, and K. Peyrollier Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration J Biol Chem 282 2007 19426 19441 (Pubitemid 47100114)
158. L.Y. Bourguignon Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression Semin Cancer Biol 18 2008 251 259
159. M. Cariati, A. Naderi, J.P. Brown, M.J. Smalley, S.E. Pinder, C. Caldas, and A.D. Purushotham Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line Int J Cancer 122 2008 298 304 (Pubitemid 350234715)
160. J. Wels, R.N. Kaplan, S. Rafii, and D. Lyden Migratory neighbors and distant invaders: tumor-associated niche cells Genes Dev 22 2008 559 574 (Pubitemid 351342429)
161. M.Z. Dewan, S. Ahmed, Y. Iwasaki, K. Ohba, M. Toi, and N. Yamamoto Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer Biomed Pharmacother 60 2006 273 276 (Pubitemid 44223937)
162. A. Muller, B. Homey, H. Soto, N. Ge, D. Catron, M.E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S.N. Wagner, J.L. Barrera, A. Mohar, E. Verástegui, and A. Zlotnik Involvement of chemokine receptors in breast cancer metastasis Nature 410 2001 50 56 (Pubitemid 32225831)
163. M.C. Smith, K.E. Luker, J.R. Garbow, J.L. Prior, E. Jackson, D. Piwnica-Worms, and G.D. Luker CXCR4 regulates growth of both primary and metastatic breast cancer Cancer Res 64 2004 8604 8612 (Pubitemid 39552073)
164. F. Andre, N. Cabioglu, H. Assi, J.C. Sabourin, S. Delaloge, A. Sahin, K. Broglio, J.P. Spano, C. Combadiere, C. Bucana, J.C. Soria, and M. Cristofanilli Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer Ann Oncol 17 2006 945 951 (Pubitemid 43778984)
165. B. Psaila, R.N. Kaplan, E.R. Port, and D. Lyden Priming the 'soil' for breast cancer metastasis: the pre-metastatic niche Breast Dis 26 2006 65 74 (Pubitemid 46647415)
166. W.T. Xu, Z.Y. Bian, Q.M. Fan, G. Li, and T.T. Tang Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis Cancer Lett 281 2009 32 41
167. K.E. Corcoran, K.A. Trzaska, H. Fernandes, M. Bryan, M. Taborga, V. Srinivas, K. Packman, P.S. Patel, and P. Rameshwar Mesenchymal stem cells in early entry of breast cancer into bone marrow PLoS One 3 2008 e2563
168. A.K. Sasser, N.J. Sullivan, A.W. Studebaker, L.F. Hendey, A.E. Axel, and B.M. Hall Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer FASEB J 21 2007 3763 3770 (Pubitemid 350075164)
169. A.E. Karnoub, A.B. Dash, A.P. Vo, A. Sullivan, M.W. Brooks, G.W. Bell, A.L. Richardson, K. Polyak, R. Tubo, and R.A. Weinberg Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 449 2007 557 563 (Pubitemid 47525152)
170. S. Pinilla, E. Alt, F.J. Abdul Khalek, C. Jotzu, F. Muehlberg, C. Beckmann, and Y.H. Song Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion Cancer Lett 284 2009 80 85
171. C. Albanese, J. Johnson, G. Watanabe, N. Eklund, D. Vu, A. Arnold, and R.G. Pestell Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions J Biol Chem 270 1995 23589 23597
172. J.M. Gee, A.F. Barroso, I.O. Ellis, J.F. Robertson, and R.I. Nicholson Biological and clinical associations of c-jun activation in human breast cancer Int J Cancer 89 2000 177 186 (Pubitemid 30185928)
173. L.M. Smith, S.C. Wise, D.T. Hendricks, A.L. Sabichi, T. Bos, P. Reddy, P.H. Brown, and M.J. Birrer cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype Oncogene 18 1999 6063 6070 (Pubitemid 29535018)
174. X. Jiao, S. Katiyar, N.E. Willmarth, M. Liu, X. Ma, N. Flomenberg, M.P. Lisanti, and R.G. Pestell c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion J Biol Chem 285 2010 8218 8226
175. S.R. Martini, G. Roman, S. Meuser, G. Mardon, and R.L. Davis The retinal determination gene, dachshund, is required for mushroom body cell differentiation Development 127 2000 2663 2672 (Pubitemid 30426813)
176. V.M. Popov, J. Zhou, L.A. Shirley, J. Quong, W.S. Yeow, J.A. Wright, K. Wu, H. Rui, R.K. Vadlamudi, J. Jiang, R. Kumar, C. Wang, and R.G. Pestell The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling Cancer Res 69 2009 5752 5760
177. K. Wu, S. Katiyar, A. Witkiewicz, A. Li, P. McCue, L.N. Song, L. Tian, M. Jin, and R.G. Pestell The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth Cancer Res 69 2009 3347 3355
178. V.M. Popov, K. Wu, J. Zhou, M.J. Powell, G. Mardon, C. Wang, and R.G. Pestell The dachshund gene in development and hormone-responsive tumorigenesis Trends Endocrinol Metab 21 2010 41 49
179. J. Zhou, C. Wang, Z. Wang, W. Dampier, K. Wu, M.C. Casimiro, I. Chepelev, V.M. Popov, A. Quong, A. Tozeren, K. Zhao, M.P. Lisanti, and R.G. Pestell Attenuation of Forkhead signaling by the retinal determination factor DACH1 Proc Natl Acad Sci USA 107 2010 6864 6869
180. K. Wu, A. Li, M. Rao, M. Liu, V. Dailey, Y. Yang, D. Di Vizio, C. Wang, M.P. Lisanti, G. Sauter, R.G. Russell, A. Cvekl, and R.G. Pestell DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth Mol Cell Biol 26 2006 7116 7129 (Pubitemid 44479729)
181. K. Wu, X. Jiao, Z. Li, S. Katiyar, M.C. Casimiro, W. Yang, Q. Zhang, N.E. Willmarth, I. Chepelev, M. Crosariol, Z. Wei, J. Hu, J. Zhao, and R.G. Pestell The cell fate determination factor dachshund reprograms breast cancer stem cell function J Biol Chem 286 2011 2132 2142
182. K. Wu, S. Katiyar, A. Li, M. Liu, X. Ju, V.M. Popov, X. Jiao, M.P. Lisanti, A. Casola, and R.G. Pestell Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8 Proc Natl Acad Sci USA 105 2008 6924 6929 (Pubitemid 351754506)
183. M.S. Hayden, and S. Ghosh Signaling to NF-kappaB Genes Dev 18 2004 2195 2224
184. M. Karin The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation J Biol Chem 274 1999 27339 27342
185. P.C. Cogswell, D.C. Guttridge, W.K. Funkhouser, and A.S. Baldwin Jr Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3 Oncogene 19 2000 1123 1131 (Pubitemid 30157541)
186. M.A. Pratt, T.E. Bishop, D. White, G. Yasvinski, M. Ménard, M.Y. Niu, and R. Clarke Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence Mol Cell Biol 23 2003 6887 6900 (Pubitemid 37220039)
187. M. Liu, X. Ju, N.E. Willmarth, M.C. Casimiro, J. Ojeifo, T. Sakamaki, S. Katiyar, X. Jiao, V.M. Popov, Z. Yu, K. Wu, D. Joyce, C. Wang, and R.G. Pestell Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo Am J Pathol 174 2009 1910 1920
188. D. Sliva, D. English, D. Lyons, and F.P. Lloyd Jr Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB Biochem Biophys Res Commun 290 2002 552 557 (Pubitemid 34694537)
189. A.B. Beshir, G. Ren, A.N. Magpusao, L.M. Barone, K.C. Yeung, and G. Fenteany Raf kinase inhibitor protein suppresses nuclear factor-kappaB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression Cancer Lett 299 2010 137 149
190. M.A. Velasco-Velázquez, Z. Yu, X. Jiao, and R.G. Pestell Cancer stem cells and the cell cycle: targeting the drive behind breast cancer Expert Rev Anticancer Ther 9 2009 275 279
191. S. Valastyan, and R.A. Weinberg MicroRNAs: crucial multi-tasking components in the complex circuitry of tumor metastasis Cell Cycle 8 2009 3506 3512
192. M. Shi, D. Liu, H. Duan, B. Shen, and N. Guo Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis Cancer Metastasis Rev 29 2010 785 799
193. Z. Yu, C. Wang, M. Wang, Z. Li, M.C. Casimiro, M. Liu, K. Wu, J. Whittle, X. Ju, T. Hyslop, P. McCue, and R.G. Pestell A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation J Cell Biol 182 2008 509 517
194. Z. Yu, N.E. Willmarth, J. Zhou, S. Katiyar, M. Wang, Y. Liu, P.A. McCue, A.A. Quong, M.P. Lisanti, and R.G. Pestell microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling Proc Natl Acad Sci USA 107 2010 8231 8236
195. M. Stahl, C. Ge, S. Shi, R.G. Pestell, and P. Stanley Notch1-induced transformation of RKE-1 cells requires up-regulation of cyclin D1 Cancer Res 66 2006 7562 7570 (Pubitemid 44289212)
196. J. Lindsay, X. Jiao, T. Sakamaki, M.C. Casimiro, L.A. Shirley, T.H. Tran, X. Ju, M. Liu, Z. Li, C. Wang, S. Katiyar, M. Rao, K.G. Allen, R.I. Glazer, C. Ge, P. Stanley, M.P. Lisanti, H. Rui, and R.G. Pestell ErbB2 induces Notch1 activity and function in breast cancer cells Clin Transl Sci 1 2008 107 115
197. H. Ling, J.R. Sylvestre, and P. Jolicoeur Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors Oncogene 29 2010 4543 4554
198. Z. Li, C. Wang, G.C. Prendergast, and R.G. Pestell Cyclin D1 functions in cell migration Cell Cycle 5 2006 2440 2442 (Pubitemid 44785818)
199. M. Korpal, E.S. Lee, G. Hu, and Y. Kang The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 J Biol Chem 283 2008 14910 14914
200. S.M. Park, A.B. Gaur, E. Lengyel, and M.E. Peter The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 [Erratum appeared in Genes Dev 2009;23:1378] Genes Dev 22 2008 894 907 (Pubitemid 351482843)
201. U. Burk, J. Schubert, U. Wellner, O. Schmalhofer, E. Vincan, S. Spaderna, and T. Brabletz A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells EMBO Rep 9 2008 582 589 (Pubitemid 351772923)
202. U. Wellner, J. Schubert, U.C. Burk, O. Schmalhofer, F. Zhu, A. Sonntag, B. Waldvogel, C. Vannier, D. Darling, A. zur Hausen, V.G. Brunton, J. Morton, O. Sansom, J. Schler, M.P. Stemmler, C. Herzberger, U. Hopt, T. Keck, S. Brabletz, and T. Brabletz The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs Nat Cell Biol 11 2009 1487 1495
203. P.C. Hermann, S.L. Huber, T. Herrler, A. Aicher, J.W. Ellwart, M. Guba, C.J. Bruns, and C. Heeschen Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1 2007 313 323 (Pubitemid 47355323)
204. A.M. Tsimberidou, F.J. Giles, E. Estey, S. O'Brien, M.J. Keating, and H.M. Kantarjian The role of gemtuzumab ozogamicin in acute leukaemia therapy Br J Haematol 132 2006 398 409 (Pubitemid 43381615)
205. T. Ozben Mechanisms and strategies to overcome multiple drug resistance in cancer FEBS Lett 580 2006 2903 2909 (Pubitemid 43729172)
206. R. Riccioni, M.L. Dupuis, M. Bernabei, E. Petrucci, L. Pasquini, G. Mariani, M. Cianfriglia, and U. Testa The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor Blood Cells Mol Dis 45 2010 86 92
207. P.B. Gupta, T.T. Onder, G. Jiang, K. Tao, C. Kuperwasser, R.A. Weinberg, and E.S. Lander Identification of selective inhibitors of cancer stem cells by high-throughput screening Cell 138 2009 645 659
208. G. Feldmann, V. Fendrich, K. McGovern, D. Bedja, S. Bisht, H. Alvarez, J.B. Koorstra, N. Habbe, C. Karikari, M. Mullendore, K.L. Gabrielson, R. Sharma, W. Matsui, and A. Maitra An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer Mol Cancer Ther 7 2008 2725 2735
209. L. Ma, F. Reinhardt, E. Pan, J. Soutschek, B. Bhat, E.G. Marcusson, J. Teruya-Feldstein, G.W. Bell, and R.A. Weinberg Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model Nat Biotechnol 28 2010 341 347
210. V.M. Platt, and F.C. Szoka Jr Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor Mol Pharm 5 2008 474 486
211. L. Jin, K.J. Hope, Q. Zhai, F. Smadja-Joffe, and J.E. Dick Targeting of CD44 eradicates human acute myeloid leukemic stem cells Nat Med 12 2006 1167 1174 (Pubitemid 44527352)
212. C. Ginestier, S. Liu, M.E. Diebel, H. Korkaya, M. Luo, M. Brown, J. Wicinski, O. Cabaud, E. Charafe-Jauffret, D. Birnbaum, J.L. Guan, G. Dontu, and M.S. Wicha CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts J Clin Invest 120 2010 485 497